We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Elsevier MDL Launches MDL® Registration Built on the MDL® Isentris® System

Read time: 1 minute

Elsevier MDL has launched the MDL® Registration application to assist life sciences research organizations with building and managing one of their assets, the corporate compound registry.

Elsevier MDL has developed a system that embodies best registration practices for organizations of all sizes.
 
Corporate compound registry systems are the lifeblood of life science research organizations.

They uniquely identify each substance and each batch of a substance, whether synthesized or procured, and enable organizations to unambiguously associate physical and biological properties, for example from biological screening, with each specific instance of the substance.
 
MDL® Registration is built on the MDL® Isentris system and provides functionality for building high-quality compound registries.

MDL Isentris is a open-technology, n-tier informatics system for integrating data, workflow applications and business processes.
 
MDL Registration also provides the foundation for custom registration projects integrating with existing applications such as an electronic laboratory notebook (ELN).

Similarly, it can be used to consolidate the separate registries of merged organizations or to migrate an existing registration system to the Isentris system.

The registration system is extensively customizable at the user interface, middle tier domain services, business rules and database levels, enabling organizations of any size to integrate it within their existing business processes.
 
"MDL Registration leverages Elsevier MDL’s industry-leading expertise in the representation and searching of chemical structures, providing research organizations with a flexible, configurable tool for registering substance, chemical structure and batch information in a central database," said Dr. Trevor Heritage, senior vice president and chief scientific officer at Elsevier MDL.

"The underlying Isentris technology enables scientists to browse chemical and biological data in a single view, making it easier for researchers to assess the outcome of an experiment or prioritize new compounds for future testing."
 
MDL Registration automatically verifies drawing conventions, normalizes structure data in accordance with corporate representation rules and checks for uniqueness before assigning corporate IDs and storing submitted substances in the database.

The system supports the integration of custom calculators to determine additional properties.

As an Isentris product, MDL Registration is tightly integrated with both MDL® Assay Explorer® and MDL® Plate Manager (for handling biological data and test samples) and with MDL® Notebook (an electronic notebook for managing laboratory workflows and data entry in an e-R&D environment).